Meropenem Venus Pharma

Meropenem, the active ingredient in Meropenem Venus Pharma, is a carbapenem antibiotic presented as a powder for solution for injection for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, septicemia and meningitis in hospitalized patients.

GNH USA supplies Meropenem Venus Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections affecting various organ systems.

Complicated intra‑abdominal infections: Provides extensive coverage against Gram‑negative, Gram‑positive and anaerobic organisms to resolve infection. Complicated urinary tract infections: Eliminates resistant uropathogens, aiding rapid clinical cure. Nosocomial pneumonia: Targets hospital‑acquired pathogens, including multidrug‑resistant strains. Septicemia: Delivers bactericidal activity in bloodstream infections. Meningitis: Achieves therapeutic concentrations in cerebrospinal fluid to treat bacterial meningitis.

Adverse reactions may occur with any antibiotic therapy.

Common Side Effects: - Nausea - Diarrhea - Rash or mild skin eruption - Headache - Phlebitis at the injection site - Transient elevation of liver enzymes

Serious or Rare Side Effects: - Seizures, especially in patients with renal impairment - Clostridioides difficile‑associated colitis - Anaphylactic or severe hypersensitivity reactions - Severe neutropenia or thrombocytopenia - Acute renal toxicity - Stevens‑Johnson syndrome or toxic epidermal necrolysis

Meropenem should be used with careful clinical monitoring. - Renal impairment: Adjust dose based on creatinine clearance. - Hepatic dysfunction: Monitor liver function tests during therapy. - Neonates and infants: Use only when clearly indicated and under specialist supervision. - Concomitant valproic acid: Increased risk of seizures; avoid if possible. - Pregnancy: Category unknown; prescribe only if potential benefit justifies the risk. - Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Valproic acid: Increases risk of seizures. - Cyclosporine: May enhance neurotoxic effects. - Aminoglycosides: Additive nephrotoxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: May affect renal clearance. - Warfarin: Potential alteration of INR. - Oral contraceptives: Possible reduction in efficacy. - NSAIDs: May increase risk of renal impairment.